Since 1999, the Cancer Clinical Trials Office (CCTO) at Beaumont Hospitals has offered personalized service to those seeking care through clinical trials. The research that you participate in today leads to tomorrow's medical treatments and disease prevention strategies, which advances evidence-based health care. In coordination with Beaumont doctors, our knowledgeable staff is committed to meeting the highest standard of excellence in conducting clinical research and supporting quality patient care.
In 2001, Beaumont was designated as a Community Clinical Oncology Program (CCOP) by the National Cancer Institute (NCI). The CCOP network was created by the NCI in 1983 to serve local communities with state-of-the art cancer prevention and treatment clinical trials. For eight years, Beaumont maintained this national designation and continues at the forefront of cancer research.
As one of only fifty CCOP designated research centers from across the U.S., we offer studies from nationally recognized cooperative groups and research bases, including:
In addition to cooperative group trials, we offer pharmaceutical, commercial, and investigator-initiated studies. Patients are participating in over 165 clinical trials.
Currently, over sixty treatment, prevention and supportive trials are open for enrollment in the following specialties:
|
Bone |
Gynecological |
Pediatric |
Multiple awards and recognitions received by Beaumont doctors and staff demonstrates the research excellence found in Cancer Clinical Trials at Beaumont Hospitals.
For more information on cancer and clinical trials you can visit the National Cancer Institute's website at: http://www.cancer.gov. There you will find information about cancer in general and insurance coverage.
Find an open and enrolling clinical trial today with Beaumont's searchable clinical trial database, or by calling 248-551-7695.
The tumor registry at Beaumont is an information system responsible for the collection, management, analysis and follow up of data on all patients with a diagnosis of malignancy or reportable benign disease.
Copyright © 2011 Beaumont Health System. All Rights Reserved.